Skip to content

Earnings yield at other companies

AdaptHealth logo
AdaptHealthAHCO
-4.9%-10.8pp
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-195.1%-206pp
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
2.9%-0.1pp
ResMed logo
ResMedRMD
4.6%+0.7pp
UFP Technologies logo
UFP TechnologiesUFPT
4.6%+0.5pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
3.4%+1.4pp

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s earnings yield?
Viemed Healthcare, Inc. (VMD) reported earnings yield of 4.2% in Q1 2026.
How has Viemed Healthcare, Inc.'s earnings yield changed year-over-year?
Viemed Healthcare, Inc.'s earnings yield decreased by 1.9% year-over-year, from 4.3% to 4.2%.
What is the long-term trend for Viemed Healthcare, Inc.'s earnings yield?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s earnings yield has grown at a -12.6% compound annual growth rate (CAGR), from 10.4% to 5.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.